Beyond Air™ to Attend the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans
October 22, 2019 16:30 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ Provides Update on High Concentration Nitric Oxide (NO) Animal Studies Using LungFit™
October 16, 2019 08:00 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ Presents Data at the 2019 European Respiratory Society (ERS) International Congress in Madrid, Spain
October 01, 2019 16:05 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ to Present at the Upcoming 2019 European Respiratory Society (ERS) International Congress in Madrid, Spain
September 23, 2019 16:25 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ to Participate at Two Upcoming Conferences
September 12, 2019 16:30 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ to Present at the 21st Annual H.C. Wainwright Global Investment Conference
September 03, 2019 16:59 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ Reports Financial Results for Fiscal First Quarter 2020
August 14, 2019 16:05 ET
|
Beyond Air™
Began trading under new ticker symbol, XAIR, on the NASDAQ stock exchange on July 15, 2019 Anticipate submitting a PMA for LungFit™* for the treatment of persistent pulmonary hypertension of the...
Beyond Air™ Participating at the BTIG Biotechnology Conference on August 12
August 05, 2019 08:00 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ Schedules First Fiscal Quarter 2020 Financial Results Conference Call and Webcast
July 30, 2019 08:00 ET
|
Beyond Air™
GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...
Beyond Air™ Announces New NASDAQ Ticker Symbol is XAIR
July 15, 2019 08:00 ET
|
AIT Therapeutics, Inc.
GARDEN CITY, N.Y. and REHOVOT, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled...